COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,891 Articles (22,568 medRxiv, 8,323 bioRxiv)

Most recent first Previous |  Page 963: Articles 9621-9630  | Next

Application of the Logistic Model to the COVID-19 Pandemic in South Africa and the United States: Correlations and Predictions
Roberts, D. H.
10.1101/2022.01.12.22269193 — Posted: 2022-01-13
Imprinted SARS-CoV-2-specific memory lymphocytes define hybrid immunity
Rodda, L. B., Morawski, P. A., Pruner, K. B., Fahning, M. L., Howard, C. A., Franko, N., Logue, J., Eggenberger, J., Stokes, C., Golez, I., Hale, M., Gale, M., Chu, H. Y., Campbell, D. J., Pepper, M.
10.1101/2022.01.12.22269192 — Posted: 2022-01-13
COVID infection severity in children under 5 years old before and after Omicron emergence in the US
Wang, L., Berger, N. A., Kaelber, D. C., Davis, P. B., Volkow, N. D., Xu, R.
10.1101/2022.01.12.22269179 — Posted: 2022-01-13
Rapid and Accurate Identification of SARS-CoV-2 Omicron Variants Using Droplet Digital PCR (RT-ddPCR)
Mills, M., Hajian, P., Bakhash, S. M., Xie, H., Mantzke, D., Zhu, H., Huang, M., Pepper, G., Jerome, K., Roychoudhury, P., Greninger, A.
10.1101/2022.01.11.22268981 — Posted: 2022-01-12
Favipiravir, umifenovir and camostat mesylate: a comparative study against SARS-CoV-2
Unal, M. A., Besbinar, O., Nazir, H., Summak, G. Y., Bayrakdar, F., Delogu, L. G., Taskin, T., Ozkan, S. A., Akcali, K. C., Yilmazer, A.
10.1101/2022.01.11.475889 — Posted: 2022-01-12
Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein
Fernandes, M. F., Chan, J. Z., Hung, C. C. J., Tomczewski, M. V., Duncan, R. E.
10.1101/2022.01.11.475901 — Posted: 2022-01-12
Structural and functional impact by SARS-CoV-2 Omicron spike mutations
Zhang, J., Cai, Y., Lavine, C., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A., Mayer, M., Rits-Volloch, S., Wang, S., Sliz, P., Wesemann, D., Yang, W., Seaman, M., Lu, J., Xiao, T., Chen, B.
10.1101/2022.01.11.475922 — Posted: 2022-01-12
Systemic infection of SARS-CoV-2 in free ranging Leopard (Panthera pardus fusca) in India
Mahajan, S., Mathesh, K., Chander, V., Pawde, A. M., Saikumar, G., Semmaran, M., Sree lakshmi, P., Sharma, M., nandi, S., Singh, K. P., Gupta, V. K., Singh, R. K., Sharma, G.
10.1101/2022.01.11.475327 — Posted: 2022-01-12
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interaction
Albornoz, E. A., Amarilla, A. A., Modhiran, N., Parker, S., Li, X. X., Wijesundara, D. K., Pliego Zamora, A., McMillan, C. L., Liang, B., Peng, N. Y. G., Sng, J. D. J., Tuj Saima, F., Paramitha, D., Parry, R., Avumegah, M. S., Isaacs, A., Lo, M., Miranda-Chacon, Z., Bradshaw, D., Salinas-Rebolledo, C., Rajapakse, N. W., Munro, T., Rojas-Fernandez, A., Young, P. R., Stacey, K. J., Khromykh, A. A., Chappell, K. J., Watterson, D., Woodruff, T. M.
10.1101/2022.01.11.475947 — Posted: 2022-01-12
UV-C light completely blocks highly contagious Delta SARS-CoV-2 aerosol transmission in hamsters
Fischer, R., Port, J. R., Holbrook, M., Yinda, K. C., Creusen, M., ter Stege, J., de Samber, M., Munster, V.
10.1101/2022.01.10.475722 — Posted: 2022-01-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).